Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A and B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00167973
What this trial is testing

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 218
Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Not applicableStudy completedNCT02796222
What this trial is testing

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Who this might be right for
Hemophilia A, CongenitalHemophilia B, Congenital
University of British Columbia 61
Early research (Phase 1)Study completedNCT00922792
What this trial is testing

Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 8
Testing effectiveness (Phase 2)Ended earlyNCT05164471
What this trial is testing

Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Who this might be right for
Hemophilia B
Spur Therapeutics 6
Not applicableStudy completedNCT05617209
What this trial is testing

In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 20
Not applicableNot Yet RecruitingNCT07657702
What this trial is testing

Effects of Anisodamine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock

Who this might be right for
Septic ShockSepsisCritical Illness
First Affiliated Hospital of Wannan Medical College 20
Not applicableStudy completedNCT02241694
What this trial is testing

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+3 more
Novo Nordisk A/S 200
Not applicableStudy completedNCT07691437
What this trial is testing

Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia Patients

Who this might be right for
Hemophilia A and BPeriodontitisHemophilia
Karadeniz Technical University 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT01434511
What this trial is testing

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 1
Testing effectiveness (Phase 2)Study completedNCT00486278
What this trial is testing

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 51
Testing effectiveness (Phase 2)Study completedNCT05027230
What this trial is testing

A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 77
Post-approval studies (Phase 4)Study completedNCT00749476
What this trial is testing

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 1
Large-scale testing (Phase 3)Ended earlyNCT04489537
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 18
Not applicableLooking for participantsNCT04398628
What this trial is testing

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Who this might be right for
Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more
American Thrombosis and Hemostasis Network 3,000
Not applicableLooking for participantsNCT04645199
What this trial is testing

National Longitudinal Cohort of Hematological Diseases

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more
Institute of Hematology & Blood Diseases Hospital, China 2,300
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Large-scale testing (Phase 3)Study completedNCT03935334
What this trial is testing

Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A or B With Inhibitor
AryoGen Pharmed Co. 48
Next Page